-
EDITORIAL
Is executive recruiting a big issue for young biotechs?
F. Martin
-
COVER STORY
Avecia Pharma Core Capabilities – Your Expert Source for Oligonucleotides, from Pre-Clinical to Commercial
-
FLOW CHEMISTRY
Microwave chemistry as a tool for flow chemistry processes
L. A. Jermolovicius, E. V. S. Pouzada, E. R. De Castro, R. B. Do Nascimento, J. T. Senise
-
FLOW CHEMISTRY
The 10th Symposium on Continuous Flow Reactor Technology for Industrial Applications – November 13-15, 2018 Milano, Italy
Santacesaria
-
FINE CHEMICALS
Disruptive technology for fine chemicals synthesis with catalyst-coated tube reactors
E. V. Rebrov, N. Cherkasov
-
SUSTAINABILITY/GREEN CHEMISTRY
Sustainability in action at an industrial scale
C. Le Ret
-
A WORD WITH
Dr. Valentino J. Stella Ph.D., Distinguished Professor Emeritus, Pharmaceutical Chemistry – The University of Kansas
-
BIG DATA/INDUSTRY 4.0
Big data in biopharmaceutical process development – vice or virtue?
M. Sokolov, F. Feidl, M. Morbidelli, A. Buttè
-
BIG DATA/INDUSTRY 4.0
Cybersecurity and business software control: do not fear the unknown, face reality!
M. R. Passerini
-
BIG DATA/INDUSTRY 4.0
Online big data chemical batch analytics
M. Hollender, M. Chioua, C. Xu
-
A WORD WITH
Marga Viñes, Business Development Manager Contract Manufacturing – Grifols International
-
POLYMER CHEMISTRY
Functional polymers for drug delivery – prospects and challenges
A. K. Pearce, A. J. Blok, G. Yilmaz, N. Singh, R. J. Cavanagh, T. Abelha, V. Taresco, C. Alexander
-
EVENTS
-
ANALYTICAL TECHNOLOGY
PAT as key-enabling technology for QbD in pharmaceutical manufacturing – A conceptual review on upstream and downstream processing
M. Kornecki, A. Schmidt, J. Strube
-
COLUMN: REGULATORY
The assessment of worker exposure in the chemical and pharma companies. How to approach a OEL/OEB determination
A. Conto
-
COLUMN: REGULATORY
Union authorisation for biocides – Easy access to the EU market
H. Kenigswald
-
COLUMN: EMERGING VALUE CHAIN
Recycling. Towards a circular economy – Part 3*
G. J. Gruter
-
COLUMN: BIOMATERIALS AND NANOMATERIALS
Single-atom catalysts: a shift in catalysis science due to impact chemical and energy industries
M. Pagliaro
-
SUPPLY CHAIN
Extractables & leachables evaluation of single-use systems for biopharmaceuticals, moving toward new industrial standards – PART 1
A. Nixdorf
-
OLIGOS & PEPTIDES
Analytical challenges in the characterisation of therapeutic oligonucleotides
A. Wake
-
ELECTROCHEMISTRY
Microfluidic electrosynthesis: a novel technology for the synthesis of drug metabolites
A. Mansfield
-
PHARMA HORIZON Regular section on - COMPLIANCE
Integration of compliance programmes an overview
A. R. Carnà
-
PHARMA HORIZON Regular section on - MERGER AND ACQUISITION
Life sciences M&As in the third quarter of 2018: notes and trends
P. D'Souza